Filing Details
- Accession Number:
- 0000950170-24-020459
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-26 19:21:02
- Reporting Period:
- 2024-02-22
- Accepted Time:
- 2024-02-26 19:21:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1054905 | Innospec Inc. | IOSP | Chemicals & Allied Products (2800) | 981081725 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1368260 | Ian Cleminson | 8310 South Valley Highway Suite 350 Englewood CO 80112 | Vp & Cfo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-02-22 | 311 | $99.85 | 21,308 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-22 | 311 | $123.96 | 20,997 | No | 4 | D | Direct | |
| Common Stock | Acquisiton | 2024-02-22 | 4,190 | $0.00 | 25,187 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2024-02-22 | 4,190 | $123.77 | 20,997 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | D | Direct | |
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Appreciation Right | Disposition | 2024-02-22 | 311 | $0.00 | 311 | $99.85 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2024-02-22 | 2031-02-22 | No | 4 | M | Direct |
Footnotes
- Stock Appreciation Right. Vested on February 22, 2024. Vested rights were paid in cash on February 22, 2024 based upon the difference in the closing price of the Company's common stock on the date of grant ($99.85, on February 22, 2021) and on the date of exercise ($123.96, on February 22, 2024).
- Shares of common stock acquired upon settlement of a performance-based restricted stock unit award granted to the reporting person on February 22, 2021.
Billionaire Hedge Funds
